Ewing sarcoma, pediatric

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 10:50, 21 July 2022 by Cafitts (talk | contribs)
Jump to navigation Jump to search

Section editor transclusions Are you looking for a regimen, but can't find it here? It is possible that we've moved it to the historical regimens page. If you still can't find it, please let us know so we can add it!

0 regimens on this page
0 variants on this page


Upfront Therapy

COG AEWS0031

Regimen A Induction

  • Regimen A is a standard regimen consisting of 21 day cycles

Cycles 1 & 3 (VDC)

  • Vincristine (Oncovin) 2 mg/m2 IV push once on day 1 (maximum dose of 2 mg)
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Doxorubicin (Adriamycin) 75 mg/m2 IV infusion over 48 hours once on day 1
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Cyclophosphamide (Cytoxan) 1200 mg/m2 IV over 1 hour on Days 1
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Mesna (Mesnex) 720 mg/m2 IV continuous infusion on day 1
  • Filgrastim (Neupogen) 5 mcg/kg SC for at least 7 days, or until ANC ≥ 750/μl, beginning on day 2
    • ANC ≥ 750/μl on or before day 7 of the cycle is not sufficient for discontinuing G-CSF

21 day cycle

Cycles 2 & 4 (IE)

  • Ifosfamide (Ifex) 1800 mg/m2 IV infusion over 1 hour once on day 1 to 5
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Etoposide (Vepesid) 100 mg/m2 IV infusion over 1 to 2 hours once on days 1 to 5
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Mesna (Mesnex) 1080 mg/m2 IV continuous infusion on day 1
  • Filgrastim (Neupogen) 5 mcg/kg SC for at least 7 days, or until ANC ≥ 750/μl, beginning on day 6
    • ANC ≥ 750/μl on or before day 7 of the cycle is not sufficient for discontinuing G-CSF

21 day cycle

Regimen A Continuation

  • At week 13 patients either underwent surgery, received radiation, or both
  • Radiation coincided with cycle 5

Cycle 5 & 9 (VDC)

Cycle 5 begins on week 15 in patients receiving surgery and on week 13 in Regimen A2
  • Vincristine (Oncovin) 2 mg/m2 IV push once on day 1 (maximum dose of 2 mg)
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Doxorubicin (Adriamycin) 75 mg/m2 IV infusion over 48 hours once on day 1
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Cyclophosphamide (Cytoxan) 1200 mg/m2 IV over 1 hour on Days 1
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Mesna (Mesnex) 720 mg/m2 IV continuous infusion on day 1
  • Filgrastim (Neupogen) 5 mcg/kg SC for at least 7 days, or until ANC ≥ 750/μl, beginning on day 2
    • ANC ≥ 750/μl on or before day 7 of the cycle is not sufficient for discontinuing G-CSF

21 day cycle

Cycle 6, 8, 10, 12, & 14 (IE)

  • Ifosfamide (Ifex) 1800 mg/m2 IV infusion over 1 hour once on day 1 to 5
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Etoposide (Vepesid) 100 mg/m2 IV infusion over 1 to 2 hours once on days 1 to 5
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Mesna (Mesnex) 1080 mg/m2 IV continuous infusion on day 1
  • Filgrastim (Neupogen) 5 mcg/kg SC for at least 7 days, or until ANC ≥ 750/μl, beginning on day 6
    • ANC ≥ 750/μl on or before day 7 of the cycle is not sufficient for discontinuing G-CSF

21 day cycle

Cycle 7 (VDC) Regimen A1 (Surgery Only)

  • Vincristine (Oncovin) 2 mg/m2 IV push once on day 1 (maximum dose of 2 mg)
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Doxorubicin (Adriamycin) 75 mg/m2 IV infusion over 48 hours once on day 1
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Cyclophosphamide (Cytoxan) 1200 mg/m2 IV over 1 hour on Days 1
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Mesna (Mesnex) 720 mg/m2 IV continuous infusion on day 1
  • Filgrastim (Neupogen) 5 mcg/kg SC for at least 7 days, or until ANC ≥ 750/μl, beginning on day 2
    • ANC ≥ 750/μl on or before day 7 of the cycle is not sufficient for discontinuing G-CSF

21 day cycle

Cycle 7 (VC) Regimen A2 & A3 (Radiation w/ or w/o Surgery)

  • Vincristine (Oncovin) 2 mg/m2 IV push once on day 1 (maximum dose of 2 mg)
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Cyclophosphamide (Cytoxan) 1200 mg/m2 IV over 1 hour on Days 1
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Mesna (Mesnex) 720 mg/m2 IV continuous infusion on day 1
  • Filgrastim (Neupogen) 5 mcg/kg SC for at least 7 days, or until ANC ≥ 750/μl, beginning on day 2
    • ANC ≥ 750/μl on or before day 7 of the cycle is not sufficient for discontinuing G-CSF

21 day cycle

Cycle 11 (VC) Regimen A1 (Surgery Only)

  • Vincristine (Oncovin) 2 mg/m2 IV push once on day 1 (maximum dose of 2 mg)
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Cyclophosphamide (Cytoxan) 1200 mg/m2 IV over 1 hour on Days 1
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Mesna (Mesnex) 720 mg/m2 IV continuous infusion on day 1
  • Filgrastim (Neupogen) 5 mcg/kg SC for at least 7 days, or until ANC ≥ 750/μl, beginning on day 2
    • ANC ≥ 750/μl on or before day 7 of the cycle is not sufficient for discontinuing G-CSF

21 day cycle

Cycle 11 (VDC) Regimen A2 & A3 (Radiation w/ or w/o Surgery)

  • Vincristine (Oncovin) 2 mg/m2 IV push once on day 1 (maximum dose of 2 mg)
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Doxorubicin (Adriamycin) 75 mg/m2 IV infusion over 48 hours once on day 1
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Cyclophosphamide (Cytoxan) 1200 mg/m2 IV over 1 hour on Days 1
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Mesna (Mesnex) 720 mg/m2 IV continuous infusion on day 1
  • Filgrastim (Neupogen) 5 mcg/kg SC for at least 7 days, or until ANC ≥ 750/μl, beginning on day 2
    • ANC ≥ 750/μl on or before day 7 of the cycle is not sufficient for discontinuing G-CSF

21 day cycle

Cycle 13 (VC)

  • Vincristine (Oncovin) 2 mg/m2 IV push once on day 1 (maximum dose of 2 mg)
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Cyclophosphamide (Cytoxan) 1200 mg/m2 IV over 1 hour on Days 1
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Mesna (Mesnex) 720 mg/m2 IV continuous infusion on day 1
  • Filgrastim (Neupogen) 5 mcg/kg SC for at least 7 days, or until ANC ≥ 750/μl, beginning on day 2
    • ANC ≥ 750/μl on or before day 7 of the cycle is not sufficient for discontinuing G-CSF

21 day cycle

Regimen B Induction

  • Regimen B is a consolidated regimen consisting of 14 day cycles

Cycles 1, 3, & 5 (VDC)

  • Vincristine (Oncovin) 2 mg/m2 IV push once on day 1 (maximum dose of 2 mg)
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Doxorubicin (Adriamycin) 75 mg/m2 IV infusion over 48 hours once on day 1
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Cyclophosphamide (Cytoxan) 1200 mg/m2 IV over 1 hour on Days 1
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Mesna (Mesnex) 720 mg/m2 IV continuous infusion on day 1
  • Filgrastim (Neupogen) 5 mcg/kg SC for at least 7 days, or until ANC ≥ 750/μl, beginning on day 2
    • ANC ≥ 750/μl on or before day 7 of the cycle is not sufficient for discontinuing G-CSF

14 day cycle

Cycle 2, 4, & 6 (IE)

  • Ifosfamide (Ifex) 1800 mg/m2 IV infusion over 1 hour once on day 1 to 5
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Etoposide (Vepesid) 100 mg/m2 IV infusion over 1 to 2 hours once on days 1 to 5
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Mesna (Mesnex) 1080 mg/m2 IV continuous infusion on day 1
  • Filgrastim (Neupogen) 5 mcg/kg SC for at least 7 days, or until ANC ≥ 750/μl, beginning on day 6
    • ANC ≥ 750/μl on or before day 7 of the cycle is not sufficient for discontinuing G-CSF

14 day cycle

Regimen B Continuation

  • At week 13 patients either underwent surgery, received radiation, or both
  • Radiation coincided with cycle 7

Cycle 7 (VDC)

Cycle 7 begins on week 15 in patients receiving surgery and on week 13 in Regimen B2
  • Vincristine (Oncovin) 2 mg/m2 IV push once on day 1 (maximum dose of 2 mg)
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Doxorubicin (Adriamycin) 75 mg/m2 IV infusion over 48 hours once on day 1
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Cyclophosphamide (Cytoxan) 1200 mg/m2 IV over 1 hour on Days 1
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Mesna (Mesnex) 720 mg/m2 IV continuous infusion on day 1
  • Filgrastim (Neupogen) 5 mcg/kg SC for at least 7 days, or until ANC ≥ 750/μl, beginning on day 2
    • ANC ≥ 750/μl on or before day 7 of the cycle is not sufficient for discontinuing G-CSF

14 day cycle


Cycle 8, 10, 12, & 14 (IE)

  • Ifosfamide (Ifex) 1800 mg/m2 IV infusion over 1 hour once on day 1 to 5
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Etoposide (Vepesid) 100 mg/m2 IV infusion over 1 to 2 hours once on days 1 to 5
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Mesna (Mesnex) 1080 mg/m2 IV continuous infusion on day 1
  • Filgrastim (Neupogen) 5 mcg/kg SC for at least 7 days, or until ANC ≥ 750/μl, beginning on day 6
    • ANC ≥ 750/μl on or before day 7 of the cycle is not sufficient for discontinuing G-CSF

14 day cycle

Cycle 9 (VDC) Regimen B1 (Surgery Only)

  • Vincristine (Oncovin) 2 mg/m2 IV push once on day 1 (maximum dose of 2 mg)
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Doxorubicin (Adriamycin) 75 mg/m2 IV infusion over 48 hours once on day 1
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Cyclophosphamide (Cytoxan) 1200 mg/m2 IV over 1 hour on Days 1
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Mesna (Mesnex) 720 mg/m2 IV continuous infusion on day 1
  • Filgrastim (Neupogen) 5 mcg/kg SC for at least 7 days, or until ANC ≥ 750/μl, beginning on day 2
    • ANC ≥ 750/μl on or before day 7 of the cycle is not sufficient for discontinuing G-CSF

14 day cycle

Cycle 9 (VC) Regimen B2 & B3 (Radiation w/ or w/o Surgery)

  • Vincristine (Oncovin) 2 mg/m2 IV push once on day 1 (maximum dose of 2 mg)
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Cyclophosphamide (Cytoxan) 1200 mg/m2 IV over 1 hour on Days 1
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Mesna (Mesnex) 720 mg/m2 IV continuous infusion on day 1
  • Filgrastim (Neupogen) 5 mcg/kg SC for at least 7 days, or until ANC ≥ 750/μl, beginning on day 2
    • ANC ≥ 750/μl on or before day 7 of the cycle is not sufficient for discontinuing G-CSF

14 day cycle

Cycle 11 (VC)

  • Vincristine (Oncovin) 2 mg/m2 IV push once on day 1 (maximum dose of 2 mg)
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Cyclophosphamide (Cytoxan) 1200 mg/m2 IV over 1 hour on Days 1
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Mesna (Mesnex) 720 mg/m2 IV continuous infusion on day 1
  • Filgrastim (Neupogen) 5 mcg/kg SC for at least 7 days, or until ANC ≥ 750/μl, beginning on day 2
    • ANC ≥ 750/μl on or before day 7 of the cycle is not sufficient for discontinuing G-CSF

14 day cycle

Cycle 13 (VC) Regimen B1 (Surgery Only)

  • Vincristine (Oncovin) 2 mg/m2 IV push once on day 1 (maximum dose of 2 mg)
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Cyclophosphamide (Cytoxan) 1200 mg/m2 IV over 1 hour on Days 1
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Mesna (Mesnex) 720 mg/m2 IV continuous infusion on day 1
  • Filgrastim (Neupogen) 5 mcg/kg SC for at least 7 days, or until ANC ≥ 750/μl, beginning on day 2
    • ANC ≥ 750/μl on or before day 7 of the cycle is not sufficient for discontinuing G-CSF

14 day cycle

Cycle 13 (VDC) Regimen B2 & B3 (Radiation w/ or w/o Surgery)

  • Vincristine (Oncovin) 2 mg/m2 IV push once on day 1 (maximum dose of 2 mg)
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Doxorubicin (Adriamycin) 75 mg/m2 IV infusion over 48 hours once on day 1
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Cyclophosphamide (Cytoxan) 1200 mg/m2 IV over 1 hour on Days 1
    • Treat with 50% doses calculated on a m2 basis for children < 1 year, then consider increasing to 75% and then to 100 % of calculated dose if tolerated
  • Mesna (Mesnex) 720 mg/m2 IV continuous infusion on day 1
  • Filgrastim (Neupogen) 5 mcg/kg SC for at least 7 days, or until ANC ≥ 750/μl, beginning on day 2
    • ANC ≥ 750/μl on or before day 7 of the cycle is not sufficient for discontinuing G-CSF

14 day cycle

References

  1. COG AEWS0031: Womer RB, West DC, Krailo MD, Dickman PS, Pawel BR, Grier HE, Marcus K, Sailer S, Healey JH, Dormans JP, and Weiss AR. Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group. J Clin Oncol. 2012 Nov 20;30(33):4148-4154. link to original article link to PMC article PubMed NCT00006734


COG AEWS1031

Regimen A Induction

  • Regimen A is a standard regimen consisting of 14 day cycles

Cycles 1, 3, & 5 (VDC)

  • Vincristine (Oncovin) 1.5 mg/m2/dose IV push once on day 1 of weeks 1, 2, 5, 6, 9 & 10 (maximum dose of 2 mg)
    • For children < 10 kg or < 1 year, the dose is 0.05 mg/kg/dose
  • Doxorubicin (Adriamycin) 37.5 mg/m2/dose IV push/infusion over 1-15 minutes on days 1 and 2 of weeks 1, 5 and 9.
    • For children < 10 kg or < 1 year, the dose is 1.25 mg/kg/dose
    • Administer at a concentration not to exceed 2 mg/mL. Doxorubicin (Adriamycin) should be administered through the tubing of rapidly infusing solution of D5W or 0.9% NaCl, and it should not be infused into a large vein
  • Cyclophosphamide (Cytoxan) 1200 mg/m2/dose IV over 30 to60 minutes on day 1 of weeks 1, 5 and 9
    • For children < 10 kg or < 1 year, the dose is 40 mg/kg/dose
    • May be administered as undiluted drug (20 mg/mL, reconstitute with 0.9% NaCl to avoid hypotonic solution) or further diluted
  • Mesna (Mesnex) 720 mg/m2/day by IV infusion or IV/PO with Cyclophosphamide (Cytoxan) on day 1 of weeks 1, 5 and 9
    • For children < 10 kg or < 1 year, the dose is 24 mg/kg/dose

14 day cycle

Cycles 2, 4, & 6 (IE)

  • Ifosfamide (Ifex) 1,800 mg/m2/dose IV infusion over 1 hour on days 1, 2, 3, 4, and 5 of Weeks 3, 7 and 11
    • For children < 10 kg or < 1 year, the dose is 60 mg/kg/dose
    • Achieve urine specific gravity ≤ 1.010 prior to start of Ifosfamide (Ifex).
  • Mesna (Mesnex) 1,080 mg/m2/day by IV infusion or IV/PO with Ifosfamide (Ifex) on days 1, 2, 3, 4, and 5 of Weeks 3, 7 and 11
    • For children < 10 kg or < 1 year, the dose is 36 mg/kg/dose
  • Etoposide (Vepesid) 100 mg/m2/dose IV infusion over 1 to 2 hours once on days 1, 2, 3, 4, and 5 of weeks 3, 7 and 11
    • For children < 10 kg or < 1 year, the dose is 3.3 mg/kg/dose

14 day cycle

Regimen A Consolidation

Regimen B Induction

Regimen B Consolidation

Retrieved from "https://hemonc.org/w/index.php?title=Ewing_sarcoma,_pediatric&oldid=57516"